- Shop Products
- Services & Tools
- Business Resources
- Clinical Resources
- Our Story
McKesson Medical-Surgical wants to help keep you informed of the most current industry Rx shortages. We continue to work with manufacturers to address shortages and to source substitute or alternate products when available.
Due to the extended market shortage and incredibly limited availability, SHINGRIX has been placed on allocation. GSK has stated that this market shortage will continue through 2019.
Merck’s ZOSTAVAX® is still on the market with no current backorder issues. ZOSTAVAX has a single-dose schedule vs. SHINGRIX’s two-dose schedule.
Note on SHINGRIX vaccination schedule: If more than six months have elapsed since a patient received their first SHINGRIX dose, administer the second dose as soon as possible. You should not restart the vaccine series. Click here for additional guidance on completing the 2-dose series of SHINGRIX.
|566601||ZOSTAVAX® Shingles Vaccine, single dose vial 19400U/.65mL (10/bx)||00006496341|
|626032||ZOSTAVAX® Shingles Vaccine, single dose vial 19400U/.65mL||00006496300|
Due to increased demand, Merck has announced that they are anticipating supply constraints for TICE BCG beginning in 2019. TICE BCG has been placed on allocation due to the market shortage.
|706308||TICE® BCG, single-use vial 50mg 2mL||00052060202|
There is currently an extended market shortage on Lidocaine. Most vials and ampules have been placed on customer allocation, however the following item is available and does not have order limits.
|1112876||Anesthetic Lidocaine HCl 10mg/mL, 1% injection ampule 5mL|
You may wish to order ampule breakers (item # 686171) and/or filtered needles with this item.
Reason for this shortage:
Pfizer Injectables is experiencing manufacturing delays. The company expects recovery dates between mid-2019 and 2020. There will be intermittent releases as product becomes available.
Auromedics, Hikma and Fresenius Kabi are experiencing a shortage due to an increase in demand. Product remains on manufacturer allocation and is shipping as supply becomes available.Pfizer Injectables Letter Dated June 22, 2017
The product information contained in this document, including the product images and additional product materials, was collected from various supplier sources. All product claims and specifications are those of the product suppliers, not McKesson Medical-Surgical or its affiliates (“McKesson”) and have not been independently verified by McKesson. McKesson is not responsible for errors or omissions in the product information.
The properties of a product may change or be inaccurate following the posting or printing of the product information in the document, either in the print or online version. Caution should be exercised when using or purchasing any products from McKesson’s online or print documents by closely examining the product packaging and the labeling prior to use.
Due to product changes, information listed in this document is subject to change without notice. This information is placed solely for your convenience in ordering and McKesson disclaims all responsibility for its completeness and accuracy, whether or not the inaccuracy or incompleteness is due to fault or error by McKesson.